0 NASDAQ Companies - June 10, 2019Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported PainRead More
0 Canadian Stock Exchange News - June 10, 2019NanoSphere Health Sciences Announces Retirement of CEO Robert E. Sutton; Dr. Mark Percival Named As SuccessorRead More
0 NYSE Companies - June 10, 2019Ferrellgas Partners, L.P. Reports Fiscal Third Quarter 2019 ResultsRead More
0 NASDAQ Companies - June 10, 2019Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus DeliveryRead More
0 NASDAQ Companies - June 10, 2019LGI Homes Announces Opening of New Community in West SacramentoRead More
0 NASDAQ Companies - June 10, 2019EyePoint Pharmaceuticals Strengthens Executive Leadership Team with Key HiresRead More
0 NASDAQ Companies - June 10, 2019Orchard Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference on June 12, 2019Read More
0 NASDAQ Companies - June 10, 2019NGM Bio to Present at Goldman Sachs 40th Annual Global Healthcare ConferenceRead More
0 NASDAQ Companies - June 10, 2019Positive Feline Clinical Trial Outcome Motivates Sorrento Therapeutics to Accelerate Human IND Filing of Resiniferatoxin (RTX) for Prolonged Non-Opioid Control of Post-Amputation Neuropathic PainRead More
